FDA Research Protocols On DTC Brief Summary Info To Be Finalized In Fall
Executive Summary
FDA expects to finalize internal protocols this fall for agency-conducted studies on the brief summary information in direct-to-consumer ads
You may also be interested in...
AstraZeneca Questions Value Of DTC Ads, But Is Still Launching New TV Spots
AstraZeneca will soon have both experimental and marketplace data to help refine its new policies on direct-to-consumer advertising
AstraZeneca Questions Value Of DTC Ads, But Is Still Launching New TV Spots
AstraZeneca will soon have both experimental and marketplace data to help refine its new policies on direct-to-consumer advertising
FDA DTC Study Should Use Real Ads, Be More Conversational – AstraZeneca
AstraZeneca is asking FDA to incorporate a more qualitative approach in the initial phase of its planned evaluation of the "brief summary" section of direct-to-consumer print advertising